ADC Therapeutics (ADCT) Treasury Shares (2019 - 2026)
ADC Therapeutics (ADCT) posted Treasury Shares of $205000.0 for Q1 2026, little changed sequentially from $205000.0 in Q4 2025, and down 0.97% YoY from $207000.0 in Q1 2025.
ADC Therapeutics (ADCT) Treasury Shares (2019 - 2026) Analysis & Trends
ADC Therapeutics has reported Treasury Shares for 8 years, with the latest figure at $205000.0 in Q1 2026.
- Quarterly Treasury Shares fell 0.97% year-over-year to $205000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205000.0 (down 0.97% YoY) and the FY2025 annual result came in at $205000.0, down 6.82% from the prior year.
- Treasury Shares held at $205000.0 in Q1 2026 per ADCT's latest filing, from $205000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $9.1 million in Q1 2026 and troughed at $2.6 million in Q1 2025.
- A 5-year average of $5.5 million and a median of $6.5 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares surged 2875.0% in 2022, then tumbled 59.33% in 2024.
- Over 5 years, Treasury Shares stood at $679000.0 in 2022, then slipped by 20.32% to $541000.0 in 2023, then sank by 59.33% to $220000.0 in 2024, then declined by 6.82% to $205000.0 in 2025, then changed by 0.0% to $205000.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $205000.0, $205000.0, and $205000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn | 205,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.39 Mn |
| Jun 30, 2026 | 205,000.00 |
| Jun 30, 2026 | 205,000.00 |
| Jun 30, 2026 | 11.39 Mn |
| Mar 31, 2026 | 205,000.00 |
| Mar 31, 2026 | 205,000.00 |
| Mar 31, 2026 | 9.07 Mn |
| Mar 31, 2026 | 9.07 Mn |
| Dec 31, 2025 | 4.62 Mn |
| Dec 31, 2025 | 4.62 Mn |
| Dec 31, 2025 | 205,000.00 |
| Dec 31, 2025 | 205,000.00 |
| Sep 30, 2025 | 205,000.00 |
| Sep 30, 2025 | 7.02 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Sep 30, 2025 | 205,000.00 |
| Jun 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 207,000.00 |